Metabolic
Retatrutide
LY3437943
Triple GIP / GLP-1 / glucagon receptor agonist
A next-generation synthetic peptide engineered as a unimolecular triple agonist at the GIP, GLP-1, and glucagon receptors. Actively studied in Phase 2/3 trials and an object of intense research interest.
For laboratory research use only. Not for human or animal consumption, not a drug, food, cosmetic, or supplement. By adding to cart, the researcher affirms compliance with all applicable regulations.
Selected research material
Retatrutide
5mg vial · SKU VRL-RET-5
Choose vial size
COA record
VRL-RET-2604
Secure checkout
Waave
Fulfillment
Cold-chain
Research price
$99
RUO only · Lot-matched documentation · Cold-chain handling
Specifications
Retatrutide is a synthetic peptide engineered as a balanced agonist at three metabolic receptors simultaneously: GIP, GLP-1, and glucagon. The molecule represents a significant step in the evolution of incretin-based research tools, extending the dual-agonist concept of Tirzepatide with an added glucagon component intended to engage hepatic and thermogenic pathways.
Published literature has investigated this compound in multi-receptor metabolic pathway models. Velour provides it only as a research reference material and makes no claim regarding therapeutic, diagnostic, cosmetic, or human/veterinary use.
Supplied as a research-grade reference peptide for investigation of triple-agonist incretin pharmacology. Not supplied for therapeutic use.
Related research tools
